News

Dislocation and decentration are, overall, the most common reasons for foldable intraocular lens (IOL) explantation, and the incidence of these complications is rising.

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs.

Multifocal intraocular lenses (IOLs) are a good choice for the right patient.

Dual optic accommodating IOLs provide a more noticeable positive impact on a patient's quality of life than multifocal IOLs, according to Andrea Galvis and Ivan Ossma of the Instituto para Ninos Ciegos y Sordos, Columbia.

Intracameral mydriatic delivery greatly simplifies cataract surgery.

The psychological outlook of patients has enormous influence on their perception of quality of life after cataract surgery, even if the outcome is poor.

Avastin (bevacizumab) is a useful adjunct for the treatment of neovascular glaucoma, but it is too soon to say if it will have a long-term impact on glaucoma therapy.

The multifocal ReSTOR (Alcon), Tecnis multifocal (AMO) and *Acri.LISA (Acri.Tec) lenses can all provide satisfactory distance and near uncorrected vision.

Patients with Type 2 diabetes undergoing cataract surgery are twice as likely to develop macula oedema than patients without diabetes.

Unlike LASEK, LASIK significantly increases irregular astigmatism in the 3 and 5 mm central zones.

Bausch & Lomb (B&L) today launched its new Stellaris Vision Enhancement system, further demonstrating its dedication to its microincision cataract surgery franchise.

Small incision cataract surgery (SICS) is a highly desirable and effective technique for India and other countries in the eastern hemisphere because it provides a highly effective and economic treatment for the vast cataract population in that part of the world.

Antibiotic-soaked IOLs could present a viable alternative to topical antibiotics for surgeons wanting to provide a sustained release of antibiotic in cataract patients.

At one-year follow-up, the aspheric Akreos Advanced Optics (Adapt AO; Bausch & Lomb) intraocular lens (IOL) achieves better high contrast uncorrected and best corrected visual acuity (UCVA & BCVA) than the conventional spherical Akreos Adapt IOL.

The incidence of spherical aberrations tends to be lower in eyes with aspherical lenses than in eyes with spherical lenses.

When it comes to correcting spherical aberration (SA) of the whole eye, customized IOLs could be a possible approach for the future. However, if high stability of corneal asphericity during cataract surgery is required, it may be necessary to make some improvements to this approach.

Automated lamellar therapeutic keratoplasty (ALTK) and Descemet stripping automated endothelial keratoplasty (DSAEK) are both safe and effective techniques for corneal transplantation.

Wavefront-guided photorefractive keratectomy (PRK) with mitomycin C (MMC) offers very similar results, when correcting compound myopic astigmatism, to wavefront-guided LASIK surgery.

Bausch & Lomb (B&L) has acquired Soothe emolliant eye drops from Alimera Sciences.

Advanced Medical Optics (AMO) has withdrawn its bid to buy Bausch & Lomb (B&L), according to a letter issued to B&L by AMO president, James V. Mazzo. The decision was made after B&L refused to grant more time to AMO to prove that it could gain the support needed from shareholders.

The German Federal Financial Supervisory Authority has approved publication of Alcon's tender offer document for WaveLight AG. This tender offer marks the second step in the completion of Alcon's acquisition of WaveLight.

TareGen has initiated a multicentre Phase II clinical trial for the topically applied TG100801 in patients with age-related macular degeneration (AMD).

Opko Health has initiated the Phase III COBALT (Combining Bevasiranib And Lucentis Therapy) clinical trial of bevasiranib for the treatment of wet age-related macular degeneration (AMD).

Regeneron Pharmaceuticals and Bayer HealthCare have initiated a Phase III study of the VEGF Trap-Eye for the treatment of wet age-related macular degeneration (AMD).

Heidelberg Engineering premiered its new perimeter technology at this year's World Glaucoma Congress in Singapore.

The Ministry of Health, Labour and Welfare in Japan has approved Alcon's treatment for glaucoma and ocular hypertension, TRAVATANZ 0.004%.

A "strong association" has been discovered between use of AMO''s Complete MoisturePlus Multi-Purpose Solution and an increased risk of Acanthamoeba keratitis (AK).

The National Institute for health and Clinical Excellence (NICE) in England is to delay issuing guidance on Lucentis and Macugen after an unprecedented patient outcry over its decision to block access to them.

Carl Zeiss Meditec AG and the Ilmenau University, Germany, have formed a partnership to open a new ophthalmic laboratory at the Institut für Biomedizinische Technik und Informatik in Germany.

ORBIS International has been awarded a $5,000,000 grant from American International Group (AIG) to ensure the growth of its long-term blindness prevention programmes in the developing world.